| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |